Association between use of antipyretics and antibody titers after two doses of the BNT162b2 SARS-CoV-2 vaccine in adolescents and young adults with underlying diseases

被引:0
作者
Aiba, Hiroyuki [1 ]
Funaki, Takanori [1 ]
Yamada, Masaki [1 ,2 ]
Miyake, Kozue [3 ]
Ueno, Saki [3 ]
Tao, Chiaki [1 ]
Myojin, Shota [1 ]
Matsui, Toshihiro [1 ]
Ogimi, Chikara [1 ]
Kato, Hitoshi [4 ]
Miyairi, Isao [1 ,5 ]
Shoji, Kensuke [1 ,6 ]
机构
[1] Natl Ctr Child Hlth & Dev, Dept Med Subspecialties, Div Infect Dis, Tokyo, Japan
[2] Natl Ctr Child Hlth & Dev, Dept Adv Med Viral Infect, Tokyo, Japan
[3] Natl Ctr Child Hlth & Dev, Dept Clin Res Promot, Tokyo, Japan
[4] Natl Ctr Child Hlth & Dev, Tokyo, Japan
[5] Hamamatsu Univ Sch Med, Dept Pediat, Shizuoka, Japan
[6] Natl Ctr Child Hlth & Dev, Dept Med Subspecialties, Div Infect Dis, 2-10-1 Okura,Setagaya ku, Tokyo 1578535, Japan
关键词
Antipyretics; Antibody titers; SARS-CoV-2; vaccine; BNT162b2; Children; RESPONSES;
D O I
10.1016/j.jiac.2023.09.025
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
There are few reports on the association between antipyretic use and antibody titers in adolescents and young adults following SARS-CoV-2 vaccination. Multivariable linear regression analyses were performed to examine the association between antipyretic use and antibody titers. The use of antipyretics was not associated with antibody titers (beta coefficient [95% CI] = -0.107 [-0.438 to 0.224]).
引用
收藏
页码:176 / 178
页数:3
相关论文
共 11 条
  • [1] Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines
    Chapin-Bardales, Johanna
    Gee, Julianne
    Myers, Tanya
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (21): : 2201 - 2202
  • [2] Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
    Frenck, Robert W., Jr.
    Klein, Nicola P.
    Kitchin, Nicholas
    Gurtman, Alejandra
    Absalon, Judith
    Lockhart, Stephen
    Perez, John L.
    Walter, Emmanuel B.
    Senders, Shelly
    Bailey, Ruth
    Swanson, Kena A.
    Ma, Hua
    Xu, Xia
    Koury, Kenneth
    Kalina, Warren V.
    Cooper, David
    Jennings, Timothy
    Brandon, Donald M.
    Thomas, Stephen J.
    Tureci, Ozlem
    Tresnan, Dina B.
    Mather, Susan
    Dormitzer, Philip R.
    Sahin, Ugur
    Jansen, Kathrin U.
    Gruber, William C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03) : 239 - 250
  • [3] Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials
    Prymula, Roman
    Siegrist, Claire-Anne
    Chlibek, Roman
    Zemlickova, Helena
    Vackova, Marie
    Smetana, Jan
    Lommel, Patricia
    Kaliskova, Eva
    Borys, Dorota
    Schuerman, Lode
    [J]. LANCET, 2009, 374 (9698) : 1339 - 1350
  • [4] Roche Diagnostics, Elecsys anti-SARS-CoV-2 package insert 2020-07, v3.0
  • [5] materialnumbers 09203095190 and 09203079190
  • [6] Effect of antipyretic analgesics on immune responses to vaccination
    Saleh, Ezzeldin
    Moody, M. Anthony
    Walter, Emmanuel B.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (09) : 2391 - 2402
  • [7] Safety of and antibody response to the BNT162b2 COVID-19 vaccine in adolescents and young adults with underlying disease
    Shoji, Kensuke
    Funaki, Takanori
    Yamada, Masaki
    Mikami, Masashi
    Miyake, Kozue
    Ueno, Saki
    Tao, Chiaki
    Myojin, Shota
    Aiba, Hiroyuki
    Matsui, Toshihiro
    Ogimi, Chikara
    Kato, Hitoshi
    Miyairi, Isao
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (01) : 61 - 66
  • [8] Correlation of Postvaccination Fever With Specific Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Booster and No Significant Influence of Antipyretic Medication
    Tani, Naoki
    Ikematsu, Hideyuki
    Goto, Takeyuki
    Gondo, Kei
    Inoue, Takeru
    Yanagihara, Yuki
    Kurata, Yasuo
    Oishi, Ryo
    Minami, Junya
    Onozawa, Kyoko
    Nagano, Sukehisa
    Kuwano, Hiroyuki
    Akashi, Koichi
    Shimono, Nobuyuki
    Chong, Yong
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (10):
  • [9] No significant influence of pre-vaccination antipyretic use on specific antibody response to a BNT162b2 vaccine booster against COVID-19
    Tani, Naoki
    Ikematsu, Hideyuki
    Goto, Takeyuki
    Gondo, Kei
    Yanagihara, Yuki
    Kurata, Yasuo
    Oishi, Ryo
    Minami, Junya
    Onozawa, Kyoko
    Nagano, Sukehisa
    Kuwano, Hiroyuki
    Akashi, Koichi
    Shimono, Nobuyuki
    Chong, Yong
    [J]. VACCINE: X, 2022, 12
  • [10] Relation of fever intensity and antipyretic use with specific antibody response after two doses of the BNT162b2 mRNA vaccine
    Tani, Naoki
    Chong, Yong
    Kurata, Yasuo
    Gondo, Kei
    Oishi, Ryo
    Goto, Takeyuki
    Minami, Junya
    Onozawa, Kyoko
    Nagano, Sukehisa
    Shimono, Nobuyuki
    Ikematsu, Hideyuki
    Kuwano, Hiroyuki
    [J]. VACCINE, 2022, 40 (13) : 2062 - 2067